Becker's Healthcare January 23, 2024
Paige Haeffele

Ongoing economic struggles have forced ASCs to update their strategy — or in some cases, face potential closure.

Although strategy changes can help alleviate some of the financial burden, medical supply costs cannot be avoided. And those supplies are getting more expensive.

Here are three figures providing insight into the medical supply market that ASCs should know:

1. Large drugmakers including Pfizer and Takeda Pharmaceuticals raised prices of more than 500 prescription drugs by approximately 5%; experts said this is typical to keep pace with inflation.

2....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Provider, Supply Chain, Survey / Study, Technology, Trends
Amazon Business helps evolve the traditional supply chain
HHS floats hospital pay incentives to strengthen drug supply
AstraZeneca plans independent drug supply chains for US and China, CEO says
Vitality in the Supply Chain: The Limitless Potential of ATMPs
Red Sea Shipping Disruptions Don’t Have Pharma Companies Seeing Red Just Yet

Share This Article